0000899243-20-033568.txt : 20201211
0000899243-20-033568.hdr.sgml : 20201211
20201211163007
ACCESSION NUMBER: 0000899243-20-033568
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201209
FILED AS OF DATE: 20201211
DATE AS OF CHANGE: 20201211
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: DUFFY MICHAEL P
CENTRAL INDEX KEY: 0001237200
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36569
FILM NUMBER: 201383831
MAIL ADDRESS:
STREET 1: C/O POINT THERAPEUTICS INC
STREET 2: 125 SUMMER STREET SUITE 1840
CITY: BOSTON
STATE: MA
ZIP: 02110
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Lantheus Holdings, Inc.
CENTRAL INDEX KEY: 0001521036
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 352318913
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 331 TREBLE COVE ROAD
CITY: NORTH BILLERICA
STATE: MA
ZIP: 01862
BUSINESS PHONE: 978 671-8001
MAIL ADDRESS:
STREET 1: 331 TREBLE COVE ROAD
CITY: NORTH BILLERICA
STATE: MA
ZIP: 01862
FORMER COMPANY:
FORMER CONFORMED NAME: Lantheus MI Holdings, Inc.
DATE OF NAME CHANGE: 20110517
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-12-09
0
0001521036
Lantheus Holdings, Inc.
LNTH
0001237200
DUFFY MICHAEL P
C/O LANTHEUS HOLDINGS, INC.
331 TREBLE COVE ROAD
NORTH BILLERICA
MA
01862
0
1
0
0
SVP and General Counsel
Common Stock
2020-12-09
4
S
0
15000
14.00
D
103402
D
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 3, 2020.
/s/ Michael P. Duffy
2020-12-11